Clinical safety of haloprogin, a new topical antimicrobial.
D000328:Adult; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism / Q000633:toxicity; D002247:Carbon Isotopes; D003877:Dermatitis, Contact / Q000139:chemically induced; D004342:Drug Hypersensitivity; D004987:Ethers / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism / Q000633:toxicity; D006801:Humans; D007509:Irritants / Q000009:adverse effects; D008297:Male; D010787:Photosensitivity Disorders / Q000139:chemically induced; D012869:Skin Absorption
D000891:Anti-Infective Agents, Local; D002247:Carbon Isotopes; D004987:Ethers; D007509:Irritants